Dewi L., Liao Y.C., Jean W.H., Huang K.C., Huang C.Y., Chen L.K., Nicholls A., Lai L.F., Kuo C.H. Cordyceps sinensis accelerates stem cell recruitment to human skeletal muscle after exercise. Food & Function. 2024;15(8):4010–4020.
Rationale
Skeletal-muscle adaptation to training is partly driven by recruitment of circulating CD34+ hematopoietic/mesenchymal progenitors and expansion of the satellite-cell pool (Pax7+). Cordyceps had previously shown immunomodulatory and anti-inflammatory action, but its influence on stem-cell recruitment to muscle had not been studied in humans. The authors hypothesized that acute immune stimulation by cordyceps might accelerate post-exercise recruitment.
Methods
A randomized double-blind placebo-controlled crossover study (Taiwan, 2024). Included 14 healthy young men aged 22–28 (24 ± 0.8), recreationally trained, without chronic disease. On two visits (≥14-day washout), participants took 1 g of standardized C. sinensis mycelium or placebo 2 hours before a high-intensity cycle-ergometer workout (Wingate test 30 s × 5). Primary outcomes: circulating CD34+ cell count and Pax7+ satellite-cell frequency in m. vastus lateralis biopsy before, and at 3 h, 24 h, 48 h after the load. Secondary: creatine kinase, lactate dehydrogenase, myoglobin (damage markers) and subjective muscle-pain scales.
Results
The C. sinensis arm showed 51% faster rise of circulating CD34+ cells by 3 h post-exercise (p = 0.002) and a 4-fold expansion of the Pax7+ satellite-cell pool (p = 0.01) versus placebo. Damage markers (creatine kinase, lactate dehydrogenase) rose less in the C. sinensis group; subjective muscle soreness (DOMS) was lower in the first 24 h. No adverse effects were noted.
Conclusions
A single 1 g dose of C. sinensis 2 h before high-intensity training accelerates mobilization of circulating CD34+ progenitors, expands the satellite-cell pool and lowers muscle-damage markers in young men. This is the first clinical evidence that cordyceps can modulate muscle regeneration at the stem-cell level in humans.
Worth noting
The crossover design in young men (n=14) gives good within-subject statistical power but says nothing about generalizability to other groups (women, the elderly, trained athletes). The single-dose effect, rather than a course, makes the data applicable to "microdosing" before a specific workout. Cellular outcomes (CD34+, Pax7+) are scientifically interesting but not yet translated into functional outcomes (e.g., strength or muscle-mass gains over 8–12 weeks of training) — that requires longer studies. The effect differs from typical adaptogens (rhodiola, eleutherococcus), where endurance rather than regeneration is the claim.